12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Aptalis Pharma, Kyowa Hakko Kirin sales and marketing update

Aptalis launched Rectiv nitroglycerin 0.4% ointment in the U.S. to treat moderate to severe pain associated with chronic...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >